Dr. Michael Schultz

Viewpoint Molecular receives $2M in SBIR funding

Dr. Michael Schultz, chief science officer with Viewpoint Molecular Targeting LLC in Coralville. CREDIT VMT   By Katharine Carlon [email protected] An innovative new method of pinpoint­ing the location of advanced skin can­cer that has spread to other parts of the…